Moderna Inc said on Thursday it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast.
It also said it is increasing its expectations for 2021 vaccine production to between 800 million and 1 billion shots, raising the bottom of its range from 700 million.
The final number of inoculations will depend on how many are lower-dose formulations for boosters and immunizations for children. Moderna shots currently deploy 100 micrograms of vaccine substance but some future shots may use only 50 micrograms.
"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," Moderna President Stephen Hoge said in an interview.